Sellas Life Sciences Group Inc (SLS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.60B
Last updated: Nov 17, 2026 at 11:06 AM ET
Sellas Life Sciences Group Inc (SLS) Stock Forecast
Analysts expect Sellas Life Sciences Group (SLS) to earn -$0.20 per share in the fiscal year ending Dec 31, 2026. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.10.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$0.20
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.10
- EPS consensus, revenue $53.09M
- Next report
- Mar 17, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.20 | -$0.20 to -$0.20 | 1 | N/A | N/A | 1 |
| Dec 31, 2027 | -$0.10 | -$0.20 to $0.00 | 2 | $53.09M | $53.09M to $53.09M | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.05 | -$0.05 to -$0.05 | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.21.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.20 | -$0.21 | -$0.21 | -$0.21 | -$0.21 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.10 | -$0.13 | -$0.13 | -$0.15 | -$0.15 | N/A |
Frequently Asked Questions About SLS
What is the SLS stock forecast?
Consensus analyst estimates put Sellas Life Sciences Group's EPS at -$0.20 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from SLS next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.20, with estimates from -$0.20 to -$0.20 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.10, with estimates from -$0.20 to $0.00 from 2 analysts.
What revenue do analysts expect from Sellas Life Sciences Group next year?
For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $53.09M, with estimates from $53.09M to $53.09M.
How many analysts cover SLS?
1 analyst estimates EPS for Sellas Life Sciences Group for the fiscal year ending Dec 31, 2026.
SLS pages: Overview, Earnings, Forecast, Financials, Competitors